Akèy › Kansè Vezik ki pa envazif miskilè › Missouri › St. Louis
Etid klinik pou Kansè Vezik ki pa envazif miskilè nan St. Louis, MO
6 etid pou Kansè Vezik ki pa envazif miskilè ap chèche patisipan nan sit nan ak bò kote St. Louis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
Ap rekriteFaz 2
- Specialty Clinical Research of St. Louis, St Louis
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
Ap rekriteEtid obsèvasyon
- Specialty Clinical Research of St Louis, St Louis
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
Ap rekriteFaz 2
- VA St.Louis Healthcare System, St Louis
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Ap rekriteFaz 2
- Renown Regional Medical Center, St Louis
- Specialty Clinic Research of St. Louis, St Louis
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Ap rekriteFaz 3
- Renown Regional Medical Center, St Louis
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Ap rekriteFaz 1
- Washington University in St. Louis, St Louis
Etid Kansè Vezik ki pa envazif miskilè nan lòt vil
- Columbus, OH10 etid
- Dallas, TX10 etid
- New York City, NY10 etid
- Myrtle Beach, SC9 etid
- Edison, NJ9 etid
- Baltimore, MD8 etid
- Syracuse, NY8 etid
- Nashville, TN8 etid
- Houston, TX7 etid
- Indianapolis, IN7 etid
- Philadelphia, PA7 etid
- Birmingham, AL7 etid
Lòt etid nan St. Louis
- Kansè Poumon ki pa ti selil73 etid
- Kansè nan tete64 etid
- Kansè Metastatik54 etid
- Kansè kolorektal50 etid
- Kansè (tout kalite)46 etid
- Kansè pwostat46 etid
- Kansè poumon39 etid
- Kansè ovè38 etid
- Kansè pankreyas33 etid
- Kansè Endomèt29 etid
- Karsinòm selil skuamèz tèt ak kou28 etid
- Ensifizyans kadyak26 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.